Skip to content

Feed Screener Search Methodology

SEC · FI · BAFIN · AFM · AMF

Pricing Sign in

InsiderLens

Statistics predict. AI explains.

Insider transactions from public regulatory disclosures, aggregated and enriched with deterministic statistical signals. Not investment advice.

Sources

SEC EDGAR · US
FINANSINSPEKTIONEN · SE
BAFIN · DE
AFM · NL
AMF · FR

Product

Methodology
Privacy notice
Object to processing

Feed Screener Search Methodology

Pricing Sign in

Kim Byong — LIPELLA PHARMACEUTICALS INC insider: 2 transactions · InsiderLens

Home / Insiders / Kim Byong

Kim Byong

Director at LIPELLA PHARMACEUTICALS INC · on record since Dec 20, 2022

Insider trading activity of Kim Byong

Transactions on record: 2; since Jun 21, 2023

Open-market buys: 0

Open-market sells: 0

Companies traded: 1; last filing Mar 19, 2024

Figures computed from official regulatory filings — methodology.

Companies where Kim Byong has traded

LIPELLA PHARMACEUTICALS INC2 tx · Mar 19, 2024

Track record of Kim Byong

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Kim Byong

Co-insiders of Kim Byong

Battleman David S.LIPELLA PHARMACEUTICALS INC
Birder LoriLIPELLA PHARMACEUTICALS INC
Chancellor Michael BLIPELLA PHARMACEUTICALS INC
Cohen Daniel RLIPELLA PHARMACEUTICALS INC
Johnston DouglasLIPELLA PHARMACEUTICALS INC
Kaufman Jonathan HLIPELLA PHARMACEUTICALS INC
Pruchnic RyanLIPELLA PHARMACEUTICALS INC

This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →

Yoshimura NaokiLIPELLA PHARMACEUTICALS INC

Company	Filed	Type	Qty	Price	Value · USD	Src
LIPELLA PHARMACEUTICALS INC	Mar 19, 2024	AwardD	25,000	0.00 USD	$0	SEC
LIPELLA PHARMACEUTICALS INC	Jun 21, 2023	AwardD	25,000	0.00 USD	$0	SEC